Literature DB >> 29895548

Primary carnitine deficiency in a 57-year-old patient with recurrent exertional rhabdomyolysis.

Andoni Echaniz-Laguna1, Valérie Biancalana2,3, Pauline Gaignard4, Jean-Baptiste Chanson1.   

Abstract

Rhabdomyolysis is an emergency requiring rapid diagnosis and suitable aetiological treatment. We describe the case of a 57-year-old man with recurrent exertional rhabdomyolysis who was diagnosed with systemic primary carnitine deficiency (SPCD). Clinical examination was normal, creatine kinase levels were elevated, plasma free carnitine concentration was mildly decreased, muscle biopsy demonstrated lipid accumulation, carnitine uptake in cultured fibroblasts was decreased and genetic analysis identified a homozygous pathologic c.1181_1183del in the SLC22A5 gene. Rhabdomyolysis did not recur after treatment with oral L-carnitine was introduced. SPCD is a rare autosomal recessive disorder of carnitine transportation usually manifesting as an infantile (hepatic) or a childhood myopathic (cardiac) condition and rarely affecting adults. Our case indicates that SPCD should be considered in the aetiological evaluation of adult patients with recurrent exertional rhabdomyolysis, even in the absence of myopathy and cardiomyopathy. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  genetic screening / counselling; muscle disease; pathology

Mesh:

Substances:

Year:  2018        PMID: 29895548      PMCID: PMC6011464          DOI: 10.1136/bcr-2018-224272

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy.

Authors:  I Tein; D C De Vivo; F Bierman; P Pulver; L J De Meirleir; L Cvitanovic-Sojat; R A Pagon; E Bertini; C Dionisi-Vici; S Servidei
Journal:  Pediatr Res       Date:  1990-09       Impact factor: 3.756

2.  Functional and molecular studies in primary carnitine deficiency.

Authors:  Marta Frigeni; Bijina Balakrishnan; Xue Yin; Fernanda R O Calderon; Rong Mao; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2017-09-14       Impact factor: 4.878

3.  Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency.

Authors:  Fang-Yuan Li; Ayman W El-Hattab; Erawati V Bawle; Richard G Boles; Eric S Schmitt; Fernando Scaglia; Lee-Jun Wong
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

4.  Genotype-phenotype correlation in primary carnitine deficiency.

Authors:  Emily C Rose; Cristina Amat di San Filippo; Uzochi C Ndukwe Erlingsson; Orly Ardon; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2011-10-11       Impact factor: 4.878

Review 5.  Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.

Authors:  Pascal Laforêt; Christine Vianey-Saban
Journal:  Neuromuscul Disord       Date:  2010-08-05       Impact factor: 4.296

6.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

7.  Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.

Authors:  Anne-Marie Lamhonwah; Simon E Olpin; Rodney J Pollitt; Christine Vianey-Saban; Priscille Divry; Nathalie Guffon; Guy T N Besley; Russell Onizuka; Linda J De Meirleir; Ljerka Cvitanovic-Sojat; Ivo Baric; Carlo Dionisi-Vici; Ksenija Fumic; Miljenka Maradin; Ingrid Tein
Journal:  Am J Med Genet       Date:  2002-08-15

Review 8.  Rhabdomyolysis: a genetic perspective.

Authors:  Renata Siciliani Scalco; Alice R Gardiner; Robert Ds Pitceathly; Edmar Zanoteli; Jefferson Becker; Janice L Holton; Henry Houlden; Heinz Jungbluth; Ros Quinlivan
Journal:  Orphanet J Rare Dis       Date:  2015-05-02       Impact factor: 4.123

Review 9.  Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management.

Authors:  Pilar L Magoulas; Ayman W El-Hattab
Journal:  Orphanet J Rare Dis       Date:  2012-09-18       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.